Abstract
To inform rational therapeutics to alleviate many senescence-related diseases in terms of the pathogenic pathways, we investigated the protective mechanisms of TLH-3 against premature senescence in tert-butyl hydroperoxide (t-BHP)-induced human embryonic lung fibroblast (HELF) cells model and d-galactose-induced premature aging mice model.We demonstrate that TLH-3 ameliorated t-BHP-induced premature senescence, which is characterized by decreased senescence-associated β-galactosidase (SA-β-Gal) positive cells containing decreased senescence effector p53 level, via up-regulating bcl-2 and down-regulated bax and caspase-3 protein expression to block t-BHP-induced inappropriate apoptosis. Furthermore, d-galactose-induced mice exhibit senescence hallmark features such as increased senescence-associated secretory phenotype characterized by increased interleukin-6 (IL-6) secretion. TLH-3 diminished age-dependent increase in circulating IL-6, lipofuscin pigment (LPF) and advanced glycation endproducts (AGEs) accumulation, the monoamine oxidase (MAO) activity and the intensity of nuclear p53 staining, which was up-regulated by d-galactose stimulation in premature aging mice. Meanwhile, TLH-3 attenuated d-galactose-induced histopathological lesions in premature aging mice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
